abstract |
(57) The present invention relates to at least one of the above-mentioned, wherein Ar represents an aryl group substituted one or more times, and R 1 , R 2 and R 3 represent a substituent defined in more detail in the claims. It relates to a medicament comprising a compound represented by formula (I). This medicament is used to reduce atherogenic Lp (a). |